H. Christoph Klingler

Medical University of Vienna

Papers

1

Total Citations

55

H-Index

1

About

H. Christoph Klingler is a distinguished urologic surgeon whose research has significantly advanced the field of minimally invasive prostate cancer surgery. His work centers on optimizing surgical techniques and improving patient outcomes, particularly in laparoscopic and robot-assisted radical prostatectomy. Dr. Klingler’s most impactful contribution is his pioneering investigation into preventing post-surgical complications, specifically lymphoceles—fluid collections that can occur after pelvic lymphadenectomy. His landmark 2011 study, cited 55 times, demonstrated that using FloSeal® hemostatic matrix dramatically reduces lymphocele incidence. This work provided a cost-effective, evidence-based solution that has since been adopted in surgical protocols worldwide, directly improving recovery for thousands of patients. Beyond this key achievement, Dr. Klingler’s broader research portfolio focuses on refining extraperitoneal surgical approaches and evaluating novel hemostatic agents. His contributions have helped shape modern standards for managing lymphatic complications, making him a respected authority in urologic oncology. For students and researchers, his work exemplifies how targeted clinical research can translate into tangible, life-changing improvements in surgical care.

Research Focus

Key Achievements

1
H-Index
1
Papers
55
Total Citations
55
Avg Citations/Paper
🏆 Most Cited Paper
Floseal Reduces the Incidence of Lymphoceles After Lymphadenectomies in Laparoscopic and Robot-Assisted Extraperitoneal Radical Prostatectomy
55 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Medical University of Vienna

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago